Your browser doesn't support javascript.
loading
Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial.
Kim, Jeongjun; Choi, Jinho; Kang, Hwankyu; Ahn, Jiye; Hutchings, Jane; Niekerk, Christo van; Kim, Jaeseung; Jeon, Yeejin; Nam, Kiyean; Kim, Tae Hwan; Shin, Beom Soo; Shin, Soyoung.
Afiliação
  • Kim J; School of Pharmacy, Sungkyunkwan University, Suwon-si, Gyeonggi-do, South Korea.
  • Choi J; Qurient Co., Ltd., Seongnam-si, Gyeonggi-do, South Korea.
  • Kang H; Qurient Co., Ltd., Seongnam-si, Gyeonggi-do, South Korea.
  • Ahn J; Qurient Co., Ltd., Seongnam-si, Gyeonggi-do, South Korea.
  • Hutchings J; Qurient Co., Ltd., Seongnam-si, Gyeonggi-do, South Korea.
  • Niekerk CV; Qurient Co., Ltd., Seongnam-si, Gyeonggi-do, South Korea.
  • Kim J; Qurient Co., Ltd., Seongnam-si, Gyeonggi-do, South Korea.
  • Jeon Y; Qurient Co., Ltd., Seongnam-si, Gyeonggi-do, South Korea.
  • Nam K; Qurient Co., Ltd., Seongnam-si, Gyeonggi-do, South Korea.
  • Kim TH; Qurient Co., Ltd., Seongnam-si, Gyeonggi-do, South Korea.
  • Shin BS; College of Pharmacy, Daegu Catholic University, Gyeongsan, Gyeongbuk, South Korea.
  • Shin S; School of Pharmacy, Sungkyunkwan University, Suwon-si, Gyeonggi-do, South Korea.
Antimicrob Agents Chemother ; 67(1): e0112322, 2023 01 24.
Article em En | MEDLINE | ID: mdl-36507677

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article